Enochian Biosciences

ENOB NASDAQ
5.43
+0.22
+4.22%
已收盘, 16:00 06/21 EDT
开盘
5.21
昨收
5.21
最高
5.50
最低
5.01
成交量
6.25万
成交均量(3M)
3.63万
52周最高
9.50
52周最低
3.320
换手率
0.16%
市值
2.11亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Enochian Biosciences ENOB股票价格,Enochian Biosciences股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Enochian Biosciences Inc, formerly DanDrit Biotech USA, Inc., is a Denmark-based biotechnology company. The Company focuses on developing vaccine against colorectal cancer. It has developed various vaccines that are used in various clinical trials in Europe and Asia, including MelCancerVac (MCV) for treatment of cancer (one phase I/II trial in Denmark and two phase II trials in Denmark and Singapore), Tolerogenic (producing immunologic tolerance) dendritic cell (TDC) (pre-clinical stage in Denmark), and Melvaccine (MV), a melanoma cell lysate used as standalone vaccine (pre-clinical state in Denmark). The Company offers MCV platform technology, which is a cellular immunotherapy for treatment of cancer. Also, the Company develops gene therapies for patients with human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS).
展开 >

最近浏览

名称
价格
涨跌幅